These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 24212628)

  • 21. Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells.
    Schwartz GK; Haimovitz-Friedman A; Dhupar SK; Ehleiter D; Maslak P; Lai L; Loganzo F; Kelsen DP; Fuks Z; Albino AP
    J Natl Cancer Inst; 1995 Sep; 87(18):1394-9. PubMed ID: 7658500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of novel modulators of protein kinase C activity upon chemotherapy-induced differentiation and apoptosis in myeloid leukemic cells.
    Meinhardt G; Eppinger E; Schmidmaier R
    Anticancer Drugs; 2002 Aug; 13(7):725-33. PubMed ID: 12187329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of intracellular signaling pathways to induce apoptosis in prostate cancer cells.
    Guo J; Zhu T; Xiao ZX; Chen CY
    J Biol Chem; 2007 Aug; 282(33):24364-72. PubMed ID: 17573344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoresistance in human ovarian cancer: the role of apoptotic regulators.
    Fraser M; Leung B; Jahani-Asl A; Yan X; Thompson WE; Tsang BK
    Reprod Biol Endocrinol; 2003 Oct; 1():66. PubMed ID: 14609433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Divergence in the anti-apoptotic signalling pathways used by nerve growth factor and basic fibroblast growth factor (bFGF) in PC12 cells: rescue by bFGF involves protein kinase C delta.
    Wert MM; Palfrey HC
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):175-82. PubMed ID: 11062070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of protein kinase C in antitumor treatment.
    Hofmann J
    Rev Physiol Biochem Pharmacol; 2001; 142():1-96. PubMed ID: 11190577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C.
    Tillman DM; Izeradjene K; Szucs KS; Douglas L; Houghton JA
    Cancer Res; 2003 Aug; 63(16):5118-25. PubMed ID: 12941843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinase C targeting in antineoplastic treatment strategies.
    Jarvis WD; Grant S
    Invest New Drugs; 1999; 17(3):227-40. PubMed ID: 10665476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein kinase C negatively regulates Akt activity and modifies UVC-induced apoptosis in mouse keratinocytes.
    Li L; Sampat K; Hu N; Zakari J; Yuspa SH
    J Biol Chem; 2006 Feb; 281(6):3237-43. PubMed ID: 16338928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parathyroid hormone-related protein confers chemoresistance by blocking apoptosis signaling via death receptors and mitochondria.
    Gagiannis S; Müller M; Uhlemann S; Koch A; Melino G; Krammer PH; Nawroth PP; Brune M; Schilling T
    Int J Cancer; 2009 Oct; 125(7):1551-7. PubMed ID: 19507249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1.
    Pang Y; Zhao Y; Wang Y; Wang X; Wang R; Liu N; Li P; Ji M; Ye J; Sun T; Li J; Ma D; Lu F; Ji C
    J Exp Clin Cancer Res; 2020 Aug; 39(1):158. PubMed ID: 32795319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells.
    Wen Y; Hou Y; Yi X; Sun S; Guo J; He X; Li T; Cai J; Wang Z
    Theranostics; 2021; 11(4):1795-1813. PubMed ID: 33408782
    [No Abstract]   [Full Text] [Related]  

  • 33. Signaling within the epithelial ovarian cancer tumor microenvironment: the challenge of tumor heterogeneity.
    Horowitz M; Esakov E; Rose P; Reizes O
    Ann Transl Med; 2020 Jul; 8(14):905. PubMed ID: 32793749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Phosphatidylinositol 3-Kinase (PI3K), Mitogen-Activated Protein Kinase (MAPK), and Protein Kinase C (PKC) in Calcium Signaling Pathways Linked to the α
    Gutiérrez A; Contreras C; Sánchez A; Prieto D
    Front Physiol; 2019; 10():55. PubMed ID: 30787881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells.
    Kruger JS; Reddy KB
    Mol Cancer Res; 2003 Sep; 1(11):801-9. PubMed ID: 14517342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein kinase C-alpha: a novel target for the therapy of androgen-independent prostate cancer? (Review-hypothesis).
    O'Brian CA
    Oncol Rep; 1998; 5(2):305-9. PubMed ID: 9468546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein kinase C inhibits singlet oxygen-induced apoptosis by decreasing caspase-8 activation.
    Zhuang S; Demirs JT; Kochevar IE
    Oncogene; 2001 Oct; 20(46):6764-76. PubMed ID: 11709711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells.
    Lee SD; Yu D; Lee DY; Shin HS; Jo JH; Lee YC
    Cancer Sci; 2019 Feb; 110(2):662-673. PubMed ID: 30485589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ex vivo assays to evaluate the role of protein kinase C in tumor cells of patients with breast cancer.
    Schöndorf T; Becker M; Kolhagen H; Kurbacher CM; Göhring UJ
    Anticancer Res; 2000; 20(6D):5073-6. PubMed ID: 11326671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway.
    Tanaka Y; Gavrielides MV; Mitsuuchi Y; Fujii T; Kazanietz MG
    J Biol Chem; 2003 Sep; 278(36):33753-62. PubMed ID: 12824193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.